4147.TWO实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 13:30):

TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes various drugs for the treatment and prevention of infectious diseases...

Stats
今日成交量	499 686
平均成交量	2.40M
市值	21.00B
EPS	TWD0 ( 2024-03-11 )
下一个收益日期	( TWD0 ) 2024-05-08
Last Dividend	TWD0 ( N/A )
Next Dividend	TWD0 ( N/A )
P/E	-109.21
ATR14	TWD0.0670 (0.08%)

音量相关性

長: -0.07 (neutral)

短: -0.83 (strong negative)

Signal:(43.984) Neutral

TaiMed Biologics Inc. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

TaiMed Biologics Inc. 相关性 - 货币/商品

-0.24
( neutral )

0.42
( neutral )

0.00
( neutral )

-0.61
( weak negative )

-0.20
( neutral )

0.67
( moderate )

TaiMed Biologics Inc. 财务报表

Annual	2023
营收:	TWD491.78M
毛利润:	TWD225.23M (45.80 %)
EPS:	TWD-0.760

FY	2023
营收:	TWD491.78M
毛利润:	TWD225.23M (45.80 %)
EPS:	TWD-0.760

FY	2022
营收:	TWD563.01M
毛利润:	TWD215.71M (38.31 %)
EPS:	TWD-1.090

FY	2021
营收:	TWD413.44M
毛利润:	TWD83.96M (20.31 %)
EPS:	TWD-1.867

Financial Reports:

No articles found.

TaiMed Biologics Inc.

TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes various drugs for the treatment and prevention of infectious diseases. The company develops and markets Ibalizumab (TMB-355) Intravenous Infusion, a humanized monoclonal antibody for the treatment of HIV-1 infection. It is also developing TMB-355 Intravenous Push, a humanized monoclonal antibody for the treatment of HIV-1 infection; TMB-355 Intramuscular Injection, a humanized monoclonal antibody intramuscular injection, which is in Phase III clinical trials for treating HIV-1; TMB-365, an anti-CD4 recombinant humanized monoclonal antibody, which completed Phase I clinical trials for treating HIV infections; and TMB-380, a neutralizing HIV-1 antibody. The company was incorporated in 2007 and is headquartered in Taipei, Taiwan.